PSMA6 and heart failure: As a non-selective β-blocker with alpha-1 antagonism, carvedilol can induce bradycardia, hypotension, or exacerbation of heart failure in susceptible individuals, particularly at doses overlapping with therapeutic windows (e.g., unbound concentrations of 0.2–2 nM).